Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05828849 · ClinicalTrials.gov registry record · NA
Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk
A NA study of Alcohol Use Disorder and Cardiovascular Disease, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT05828849 is a NA study of Alcohol Use Disorder and Cardiovascular Disease that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 87 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05828849, a NA study of Alcohol Use Disorder and Cardiovascular Disease, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs borne by patients) will help people reduce their chances of dying from preventable causes, including heart attacks, strokes, drinking alcohol, substance abuse, HIV, and other conditions.
Conditions Studied
Interventions
- BEHAVIORAL Navigation, compensation, and personalization
Study Locations (1)
New York
- NYC H+H/Bellevue - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2024-06-25 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05828849
The ClinicalTrials.gov registry entry for NCT05828849 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (73% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Navigation, compensation, and personalization is the first listed.
NCT05828849 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05828849 about?
NCT05828849 is a clinical study titled "Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk". The purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs borne by patients) wi...
What is the current status of trial NCT05828849?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 87 participants. The study started on 2024-06-25. Estimated completion is 2026-07.
What conditions does trial NCT05828849 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Cardiovascular Disease, Substance Use Disorders, HIV Risk.
What interventions are being tested in trial NCT05828849?
The interventions under investigation include: Navigation, compensation, and personalization (BEHAVIORAL).
Who is sponsoring clinical trial NCT05828849?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05828849 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.